FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:720-722 August 16, 2007 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: Nephrogenic systemic fibrosis is a newly described systemic disorder that occurs in patients with renal insufficiency.^1,2 The functional consequences of nephrogenic systemic fibrosis are often devastating and may be fatal. Since nephrogenic systemic fibrosis develops after exposure to gadolinium-containing magnetic resonance contrast agents in some patients,³ the Food and Drug Administration recommended avoiding such agents in patients with renal insufficiency. The mechanism by which nephrogenic systemic fibrosis develops after gadolinium exposure remains unknown.

Gadolinium is administered as a chelate, since free gadolinium is toxic. Metals such as iron are capable of inducing the dissociation of gadolinium from . . . [Full Text of this Article]

This article has been cited by other articles:

• Prince, M. R., Zhang, H., Morris, M., MacGregor, J. L., Grossman, M. E., Silberzweig, J., DeLapaz, R. L., Lee, H. J., Magro, C. M., Valeri, A. M. (2008). Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers. Radiology 248: 807-816 [Abstract] [Full Text]  
• Kane, G. C., Stanson, A. W., Kalnicka, D., Rosenthal, D. W., Lee, C. U., Textor, S. C., Garovic, V. D. (2008). Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Nephrol Dial Transplant 23: 1233-1240 [Abstract] [Full Text]  
• Swaminathan, S., Shah, S. V. (2007). New Insights into Nephrogenic Systemic Fibrosis. J. Am. Soc. Nephrol. 18: 2636-2643 [Abstract] [Full Text]